Details of the Drug-Related molecule(s) Expression Atlas
General Information of Drug (ID: DMQUKBG)
Drug Name | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
Carcinine; 56897-53-1; N-(2-(1H-Imidazol-5-yl)ethyl)-3-aminopropanamide; beta-Alanylhistamine; UNII-WIV0W167TC; WIV0W167TC; N-[2-(1H-imidazol-5-yl)ethyl]-beta-alaninamide; SPBio_002343; beta-alaninylhistamine; N-beta-alanylhistamine; AC1L1DZE; Prestwick2_000422; Prestwick1_000422; Prestwick0_000422; Prestwick3_000422; Lopac-C-2321; AC1Q5P6Q; n-[2-(1h-imidazol-5-yl)ethyl]-; A-alaninamide; Lopac0_000210; BSPBio_000404; KSC921E6R; MLS002153803; SCHEMBL2819350; CHEMBL461024; BPBio1_000446; SCHEMBL19051459; CHEBI:95262; CTK8C1268
|
|||||||||||||||||||
Indication |
|
|||||||||||||||||||
Cross-matching ID | ||||||||||||||||||||
Molecule(s) Related to This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs
|
||||||||||||||||||||||||||
Molecule Expression Atlas in Normal Tissue of Major ADME-related organs | ||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas between Disease Section and Healthy Individual Tissue | ||||||||||||||||||||||||